United States · Bill · HR
H.R. 3627 (109th)
Rapid Pathogen Identification to Delivery of Cures Act
Introduced
29 July 2005
Last action
19 September 2005 · Referred
Status
Referred to the Subcommittee on Terrorism, Unconventional Threats and Capabilities.
Sponsors
Del. Christensen, Donna M. [D-VI-At Large], Bennie Thompson, Rep. Dicks, Norman D. [D-WA-6], Zoe Lofgren, JAMES LANGEVIN
Subjects
Healthcare, Defence
Source updated
15 August 2025
Summary
Rapid Pathogen Identification to Delivery of Cures Act - Amends the Homeland Security Act of 2002 to require the Secretary of Homeland Security to submit a report setting forth a strategy to reduce the time frame from pathogen identification to the development and emergency approval for human use of a reasonably safe and effective priority countermeasure against a novel or unknown pathogen or toxin. Requires the report to include: (1) technical impediments to reducing this time frame; (2) research, development, and technology needs to address these impediments; and (3) potential liability concerns stemming from distribution of rapidly-developed priority countermeasures. Allows the Secretary to contract with any firm or institution to conduct necessary research and analysis for this report. Requires the Secretary of Health and Human Services (HHS) to establish a system to rapidly: (1) establish clinical research programs to examine the safety and efficacy of treatments for novel, unknown, or bioengineered pathogens or toxins; and (2) disseminate results and recommendations to clinicians. Authorizes establishment of a fund to support such clinical research. Requires the Secretary of Homeland Security to establish an interagency working group to carry out this Act. Amends the Public Health Service Act to require the Secretary of HHS to conduct research to rapidly identify, develop, produce, and approve for human use priority countermeasures. Requires the Secretaries of Defense and HHS to carry out research, development, and procurement to provide the federal government with the capability to rapidly identify, develop, produce, and approve for human use under emergency conditions priority countermeasures against a novel, unknown, or engineered pathogen or toxin for which no existing countermeasure has been determined to be safe or efficacious.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
29 July 2005
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Armed Services, and Homeland Security, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
29 July 2005
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Armed Services, and Homeland Security, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
29 July 2005
Introduced
Sponsor introductory remarks on measure. (CR E1712)
Source: IntroReferral
29 July 2005
Introduced
Introduced in House
Source: IntroReferral
29 July 2005
Introduced
Introduced in House
Source: IntroReferral
5 August 2005
Referred
Referred to the Subcommittee on Health.
Source: Committee
22 August 2005
Referred
Referred to the Subcommittee on Emergency Preparedness, Science, and Technology.
Source: Committee
19 September 2005
Referred
Referred to the Subcommittee on Terrorism, Unconventional Threats and Capabilities.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 29 July 2005 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 29 July 2005
Introduced in House (PDF)
Introduced in House · EN · 29 July 2005
Introduced in House
summary · EN · 29 July 2005
Sponsors
- Del. Christensen, Donna M. [D-VI-At Large] · D · Sponsor
- Bennie Thompson · D · Sponsor
- Rep. Dicks, Norman D. [D-WA-6] · D · Sponsor
- Zoe Lofgren · D · Sponsor
- JAMES LANGEVIN · D · Sponsor
- · hsas00 · Standing
- · hshm00 · Standing
- · hsif00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/109th-congress/house-bill/3627
- Open data entity: https://api.congress.gov/v3/bill/109/hr/3627
- us · 109-hr-3627 · source updated 15 August 2025